Tag: Monsanto

BASF to Buy Bayer’s Seed Assets for Billions

BASF to Buy Bayer’s Seed Assets for Billions

October 21, 2017 |

In New Jersey, BASF agreed to buy almost all of Bayer’s seed assets including LibertyLink seeds and chemistry for $7 billion, assuming the Bayer acquisition of Monsanto goes through. If all goes as planned, BASF will gain 1,800 Bayer employees, 700 of them in North America and 81 Bayer sites. This is BASF’s first time […]

Read More

Evogene hits milestones in crop disease tie up with Monsanto

Evogene hits milestones in crop disease tie up with Monsanto

July 11, 2017 |

In Israel, Evogene Ltd. announced it had reached an important milestone in its crop disease collaboration with Monsanto Company with the demonstration of positive Fusarium resistance results with Evogene discovered genes. Additionally, Evogene announced the completion of the candidate gene discovery stage in the companies’ yield and abiotic stress collaboration, which mainly focuses on corn […]

Read More

Monsanto lands license for new CRISPR System

Monsanto lands license for new CRISPR System

January 8, 2017 |

In Missouri, Monsanto has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance in genome-editing technology, because it has potential to be a simpler and more precise tool for making targeted improvements […]

Read More

The Emerging Bioeconomy Ecosystems

The Emerging Bioeconomy Ecosystems

December 7, 2016 |

In political circles, the theme of “Better Together” has been under siege of late — barely winning (for now) in the Sctoland independence, debate, and losing unexpectedly in the Brexit vote — but it remains a theme for surviving and thriving in the advanced bioeconomy. We tipped it a few months ago, in “The Rise […]

Read More

Hook-Up of the Year: The Digest’s 2016 Multi-Slide Guide to Bayer & Monsanto

Hook-Up of the Year: The Digest’s 2016 Multi-Slide Guide to Bayer & Monsanto

September 20, 2016 |

Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Bayer and Monsanto put together this deck on the […]

Read More

Bayer-Monsanto Hook Up: Good News or Bad Tidings for the Advanced Bioeconomy?

Bayer-Monsanto Hook Up: Good News or Bad Tidings for the Advanced Bioeconomy?

September 20, 2016 |

Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 per share all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Reactions to the deal fall into three […]

Read More

Strategic Intent: The Digest 2016 Multi-Slide Guide to Bayer, Bunge and Monsanto

Strategic Intent: The Digest 2016 Multi-Slide Guide to Bayer, Bunge and Monsanto

August 24, 2016 |

This season, we are conducting Strategic Intent, our 19 webinar series on major companies and their partnerships, progress and plans in the Advanced Bioeconomy. In this edition, we explored Bayer, Bunge and Monsanto in the interactive webinar format. Here are the slides from our Digest presentation, focusing on the innovations, M&A activity, target molecules and more for […]

Read More

Syngenta rebuffs Monsanto $45B offer as key shareholders say $50B might do the trick

Syngenta rebuffs Monsanto $45B offer as key shareholders say $50B might do the trick

May 10, 2015 |

In Switzerland, the Board of Syngenta confirmed that it has received an unsolicited proposal from Monsanto to acquire the company at a price of $45 billion (CHF449 per Syngenta share) with approximately 45 percent in cash. Reporting on the proposed acquisition has sugested that key Syngenta shareholders would back a deal which valued Syngenta at […]

Read More

Evogene incorporates gene optimization program in R&D with Monsanto

Evogene incorporates gene optimization program in R&D with Monsanto

February 4, 2015 |

In Israel, Evogen announced that its recently developed comprehensive gene optimization program is being incorporated into its multi-year collaboration with Monsanto Company. The addition of these new capabilities, which have been designed to optimize desired trait efficacy and potentially accelerate product development, follows the successful identification and validation by Evogene of more than one thousand […]

Read More

DuPont and Monsanto agree to settlement, dismiss litigation

DuPont and Monsanto agree to settlement, dismiss litigation

December 29, 2014 |

In Missouri, DuPont and Monsanto have announced that they have agreed on a settlement regarding their patent infringement lawsuits pending in the U.S. District Court in St. Louis, and that they will be dismissing the suits. Upon dismissal, the two companies will have no litigation against each other. The terms of the settlement are not […]

Read More